Related Experiment Videos
Hepatic angiomyolipoma: progressive changes in size and tumor composition
1Unitat de Diagnòstic per la Imatge d'Alta Tecnología, Corporació Sanitaria del Parc Taulf, Parc-Tauli s/n, 08208 Sabadell, Spain.
Abdominal Imaging
|November 25, 2003
Summary
Hepatic angiomyolipomas (AMLs) can grow significantly over time, particularly their fatty components. This 8-year follow-up highlights that radiologists should monitor hepatic AMLs for potential tumor growth.
Area of Science:
- Hepatology
- Oncology
- Radiology
Background:
- Hepatic angiomyolipomas (AMLs) are benign liver tumors.
- Understanding the growth patterns of hepatic AMLs is crucial for patient management.
Observation:
- This study presents 8 years of imaging and clinical data for a hepatic AML.
- The tumor demonstrated notable growth over the observation period.
Findings:
- Significant tumor growth occurred in the first 5 years, primarily affecting the fatty component.
- Slower growth was observed in the subsequent 3 years.
- The hepatic AML showed continuous, albeit variable, growth over 8 years.
Implications:
- Radiologists must be aware of the potential for hepatic AML growth.
- Long-term imaging surveillance may be necessary for hepatic AMLs.
- This case underscores the importance of monitoring benign liver lesions for changes.